Inflammatory bowel diseases (IBD) arise from a convergence of genetic risk, environmental
factors, and gut microbiota, where each is necessary but not sufficient to cause disease …

The intestinal microbiota encompasses hundreds of bacterial species that constitute a
relatively stable ecosystem. Alteration in the microbiota composition may arise from …

Inflammatory bowel diseases (IBD) develop via convergence of environmental, microbial,
immunological, and genetic factors. Alterations in the gut microbiota have been associated …

Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative
colitis (UC), has emerged as a global disease with high incidence, long duration …

Inflammatory bowel disease (IBD) has become a global disease with accelerating incidence
worldwide in the 21st century while its accurate etiology remains unclear. In the past …

In the twenty first century, the changing epidemiology of inflammatory bowel disease (IBD)
globally with increasing disease incidence across many countries relates to the altered gut …

Inflammatory bowel diseases (IBD) are a group of chronic diseases of increasing worldwide
prevalence characterized by gastrointestinal (GI) inflammation leading to debilitating …

Inflammatory bowel disease (IBD) is a chronic and relapsing inflammatory disorder of the
gut. Although the precise cause of IBD remains unknown, the most accepted hypothesis of …

Crohn's disease (CD) is a systemic chronic inflammatory condition mainly characterized by
discontinuous transmural pathology of the gastrointestinal tract and frequent extraintestinal …

Inflammatory bowel diseases (IBD) are chronic medical disorders characterized by recurrent
gastrointestinal inflammation. While the etiology of IBD is still unknown, the pathogenesis of …